KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Mar 25, 2026 - 3:59PM >>  ABB India 6246.85  [ 1.45% ]  ACC 1368.7  [ 2.59% ]  Ambuja Cements 419.25  [ 2.87% ]  Asian Paints 2285.3  [ 3.09% ]  Axis Bank 1232.95  [ 3.44% ]  Bajaj Auto 9121  [ 2.49% ]  Bank of Baroda 274.5  [ 1.39% ]  Bharti Airtel 1842.4  [ 2.15% ]  Bharat Heavy 264.95  [ 2.65% ]  Bharat Petroleum 285  [ 0.97% ]  Britannia Industries 5727  [ 3.91% ]  Cipla 1248.75  [ 2.42% ]  Coal India 445.4  [ 0.79% ]  Colgate Palm 1911.5  [ 1.80% ]  Dabur India 435.65  [ 3.36% ]  DLF 534.2  [ 2.49% ]  Dr. Reddy's Lab. 1301.7  [ 3.34% ]  GAIL (India) 139.3  [ 1.13% ]  Grasim Industries 2656.55  [ 4.35% ]  HCL Technologies 1401.5  [ 2.05% ]  HDFC Bank 792.6  [ 3.59% ]  Hero MotoCorp 5336.35  [ 1.61% ]  Hindustan Unilever 2150  [ 3.13% ]  Hindalco Industries 869.4  [ 1.74% ]  ICICI Bank 1265.6  [ 1.11% ]  Indian Hotels Co. 617.55  [ 2.23% ]  IndusInd Bank 820.95  [ 2.87% ]  Infosys 1287.55  [ 0.73% ]  ITC 297  [ 1.99% ]  Jindal Steel 1140.4  [ 1.81% ]  Kotak Mahindra Bank 366.65  [ -0.14% ]  L&T 3643.5  [ 3.65% ]  Lupin 2351.4  [ 0.84% ]  Mahi. & Mahi 3144.05  [ 3.68% ]  Maruti Suzuki India 12733.85  [ 2.14% ]  MTNL 25.2  [ 5.40% ]  Nestle India 1212.6  [ 2.52% ]  NIIT 57.55  [ 5.15% ]  NMDC 78.19  [ 1.94% ]  NTPC 380.5  [ 1.35% ]  ONGC 270.5  [ 0.90% ]  Punj. NationlBak 110.65  [ 3.17% ]  Power Grid Corpn. 297.4  [ -0.60% ]  Reliance Industries 1423.5  [ 0.85% ]  SBI 1063  [ 3.12% ]  Vedanta 672  [ 3.11% ]  Shipping Corpn. 236  [ 2.54% ]  Sun Pharmaceutical 1797.9  [ 2.57% ]  Tata Chemicals 631.3  [ 3.65% ]  Tata Consumer 1068.7  [ 1.47% ]  Tata Motors Passenge 320.75  [ 3.05% ]  Tata Steel 196.25  [ 2.80% ]  Tata Power Co. 393.4  [ 2.25% ]  Tata Consult. Serv. 2407.6  [ 0.37% ]  Tech Mahindra 1422.05  [ -0.76% ]  UltraTech Cement 11168  [ 3.78% ]  United Spirits 1317  [ -0.80% ]  Wipro 189.85  [ 0.58% ]  Zee Entertainment 76.37  [ 6.78% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

25 March 2026 | 03:51

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 204.24 Face Value 10.00
Bookclosure 19/09/2025 52Week High 544 EPS 5.24 P/E 47.91
Market Cap. 340.54 Cr. 52Week Low 237 P/BV / Div Yield (%) 1.23 / 0.40 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh. MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales. MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively. 2010 -The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share) -The Company appointed Mr. B.K.Gupta as Managing Director. 2011 -The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan. 2013 -Ms. Harshita Sharma has been appointed as Additional Director of the company. 2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd. 2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant. 2020 -Global API Facility started Dahej API Plant. 2021 -Operations started Haridwar formulation Unit II(FDF). 2023 -Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024
-Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
-Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.